627

BIOLOGICAL2 trials

Sponsors

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Conditions

Healthy Subjects (HS)Ulcerative Colitis (UC)

Phase 1

Evaluation of 627 in Healthy Adult Subjects

Not yet recruitingNCT07065136

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Healthy Subjects (HS)

Start: 2025-07-20End: 2026-09-18Target: 108Updated: 2025-07-15

Phase 2

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

RecruitingNCT07507513

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Ulcerative Colitis (UC)

Start: 2026-03-28End: 2029-12-30Target: 288Updated: 2026-07-28